Advaxis, Inc.

ADXS

Insider trading at Advaxis, Inc.

Transactions on record: 792; since Dec 10, 2004

Insider buys: 30; $19.9M

Insider sells: 51; $11M

Active insiders · 12 months: 0; last filing Mar 6, 2024

Figures computed from official regulatory filings — methodology.

Current insiders at Advaxis, Inc.

Adage Capital Advisors, L.L.C.10% owner
ADAGE CAPITAL PARTNERS GP LLC10% owner
ADAGE CAPITAL PARTNERS LP10% owner
aMoon 2 Fund Limited Partnership10% owner
APPEL RONIDirector
APPEL RONIChief Financial Officer
APPEL RONI10% owner
Atchinson Robert10% owner
Berlin Kenneth ADirector
Berlin Kenneth APresident and CEO
BERMAN RICHARD JDirector
Bisker-Leib VeredDirector
Bonstein SaraDirector
Bonstein SaraChief Financial Officer
Cabilly YuvalDirector
COBB FREDRICK DVice President Finance
DERBIN JON TODDDirector
DERBIN JON TODDCEO and President
FLAMM SCOTTDirector
FRENCH CHRISTY LEEVP-Regulatory, Medical Affairs
Gitelman IgorChief Accounting Officer
Golan RoyChief Financial Officer
GOLDBERG MURRAY ADirector
Gross Phillip10% owner
GUTIERREZ ANDRESExecutive Vice President & CMO
Henderson MollyExecutive Vice President & CFO
I.B.F. Management Ltd.Director
I.B.F. Management Ltd.10% owner
Israel Biotech Fund GP Partners II, L.P.Director
Israel Biotech Fund GP Partners II, L.P.10% owner
Israel Biotech Fund GP Partners, L.P.Director
Israel Biotech Fund GP Partners, L.P.10% owner
Israel Biotech Fund II, L.P.Director
Israel Biotech Fund II, L.P.10% owner
Israel Biotech Fund I, L.P.Director
Israel Biotech Fund I, L.P.10% owner
Khleif Samir NDirector
LOMBARDO ANTHONY AInterim CEO
LOW NATHAN A10% owner
Martell Bridget ADirector
Mauro David JChief Medical Officer
Mayes, Gregory T.Director
Mayes, Gregory T.Chief Business Officer
MCKEARN THOMAS JDirector
MOORE THOMAS ADirector
MOORE THOMAS ACEO, Chairman of the Board
MOORE THOMAS AFormer Director
O'Connor DanielDirector
O'Connor DanielChief Executive Officer
Orbach PiniDirector
PATTON JAMES PDirector
PETIT ROBERTChief Scientific Officer
Ridge Thomas JDirector
Rosenblum Mark JChief Financial Officer
ROTHMAN JOHN FExec VP of Science and Ops
ROTH STEPHEN ALLENDirector
Schindel Yair Chaim10% owner
SIDRANSKY DAVIDDirector
Spiegel Robert J.Director
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA10% owner
WADE MARTIN R IIIDirector

Insider	Filed	Type	Qty	Price	Value · USD	Src
Israel Biotech Fund I, L.P.	Mar 6, 2024	ExerciseD	1,500,000	—	—	SEC
Israel Biotech Fund I, L.P.	Mar 6, 2024	ExerciseD	2,250,000	—	—	SEC
Israel Biotech Fund I, L.P.	Mar 6, 2024	ExerciseD	1,500,000	—	—	SEC
Israel Biotech Fund I, L.P.	Mar 6, 2024	ExerciseD	2,250,000	—	—	SEC
Israel Biotech Fund I, L.P.	Mar 6, 2024	ExerciseD	-3,750,000	—	—	SEC
Israel Biotech Fund I, L.P.	Mar 6, 2024	ExerciseD	-3,750,000	—	—	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	Exercise	8,437,500	0.40 USD	$3.4M	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	Exercise	8,062,500	0.40 USD	$3.2M	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	Exercise	1,926,221	0.40 USD	$770.5K	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	ExerciseD	-1,926,221	—	—	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	ExerciseD	-4,237,687	—	—	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	ExerciseD	-1,295,813	—	—	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	Other	-2,707,581	1.25 USD	$3.4M	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	Exercise	3,887,438	0.40 USD	$1.6M	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	Other	-2,586,905	1.25 USD	$3.2M	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	Exercise	1,295,813	0.40 USD	$518.3K	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	ExerciseD	-8,062,500	—	—	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	ExerciseD	-3,887,438	—	—	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	Exercise	4,237,687	0.40 USD	$1.7M	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	ExerciseD	-8,437,500	—	—	SEC
Israel Biotech Fund GP Partners, L.P.	Nov 21, 2023	BuyD	6,187,500	—	—	SEC
Israel Biotech Fund GP Partners, L.P.	Nov 21, 2023	BuyD	2,812,500	—	—	SEC
Israel Biotech Fund GP Partners, L.P.	Nov 21, 2023	BuyD	3,150,000	—	—	SEC
Israel Biotech Fund GP Partners, L.P.	Nov 21, 2023	BuyD	4,687,500	—	—	SEC
Israel Biotech Fund GP Partners, L.P.	Nov 21, 2023	BuyD	0	—	—	SEC

Insider	Filed	Type	Qty	Price	Value · USD	Src
Israel Biotech Fund I, L.P.	Mar 6, 2024	ExerciseD	1,500,000	—	—	SEC
Israel Biotech Fund I, L.P.	Mar 6, 2024	ExerciseD	2,250,000	—	—	SEC
Israel Biotech Fund I, L.P.	Mar 6, 2024	ExerciseD	1,500,000	—	—	SEC
Israel Biotech Fund I, L.P.	Mar 6, 2024	ExerciseD	2,250,000	—	—	SEC
Israel Biotech Fund I, L.P.	Mar 6, 2024	ExerciseD	-3,750,000	—	—	SEC
Israel Biotech Fund I, L.P.	Mar 6, 2024	ExerciseD	-3,750,000	—	—	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	Exercise	8,437,500	0.40 USD	$3.4M	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	Exercise	8,062,500	0.40 USD	$3.2M	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	Exercise	1,926,221	0.40 USD	$770.5K	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	ExerciseD	-1,926,221	—	—	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	ExerciseD	-4,237,687	—	—	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	ExerciseD	-1,295,813	—	—	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	Other	-2,707,581	1.25 USD	$3.4M	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	Exercise	3,887,438	0.40 USD	$1.6M	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	Other	-2,586,905	1.25 USD	$3.2M	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	Exercise	1,295,813	0.40 USD	$518.3K	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	ExerciseD	-8,062,500	—	—	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	ExerciseD	-3,887,438	—	—	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	Exercise	4,237,687	0.40 USD	$1.7M	SEC
Israel Biotech Fund GP Partners, L.P.	Feb 12, 2024	ExerciseD	-8,437,500	—	—	SEC
Israel Biotech Fund GP Partners, L.P.	Nov 21, 2023	BuyD	6,187,500	—	—	SEC
Israel Biotech Fund GP Partners, L.P.	Nov 21, 2023	BuyD	2,812,500	—	—	SEC
Israel Biotech Fund GP Partners, L.P.	Nov 21, 2023	BuyD	3,150,000	—	—	SEC
Israel Biotech Fund GP Partners, L.P.	Nov 21, 2023	BuyD	4,687,500	—	—	SEC
Israel Biotech Fund GP Partners, L.P.	Nov 21, 2023	BuyD	0	—	—	SEC

Advaxis, Inc.

Insider trading at Advaxis, Inc.

Current insiders at Advaxis, Inc.

Advaxis, Inc.

Insider trading at Advaxis, Inc.

Current insiders at Advaxis, Inc.

Insider transaction history at Advaxis, Inc.

Insider transaction history at Advaxis, Inc.